ARIAD science:
focus, innovation and discipline.
ARIAD represents a long history of scientific excellence, with special expertise in the design and characterization of small-molecule cancer drugs. We have operated at the forefront of discovery for our entire 15-plus-year history—with deep knowledge across key areas that form a solid base for solving cancer’s most difficult problems.
How ridaforolimus works
ARIAD’s lead product candidate, ridaforolimus, is a novel, potent mTOR inhibitor in development for multiple oncology indications.
©2010 ARIAD Pharmaceuticals, Inc.